URAT1 Inhibitor Beats Allopurinol for Treating Gout Arthritis With Tophi
AR882 is a novel and selective URAT1 inhibitor currently in clinical stage development for the treatment of gout with tophi.
Source: empr.com
Energy Computer Tomography News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Energy Computer Tomography. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Energy Computer Tomography Today - Breaking & Trending Today
URAT1 Inhibitor Beats Allopurinol for Treating Gout Arthritis With Tophi
The investigational drug AR882 appeared more effective and safer than allopurinol monotherapy in a phase 2 trial. AR882 is a novel and selective URAT1 inhibitor currently in clinical stage development for the treatment of gout with tophi.
Source: renalandurologynews.com
AR882 Lowers Serum Urate in Patients with Gout
At month 6, more patients in the AR882 75 mg cohort demonstrated complete resolution of ≥1 tophus compared with patients in the allopurinol cohort.
Source: hcplive.com
Sustained Serum Urate Reduction for Gout Patients Observed with AR882
In this data shown at ACR 2023, the URAT1 inhibitor known as AR882 showed promising phase 2b data for patients with gout.
Source: hcplive.com